Publicacións nas que colabora con Gema Moreno Bueno (20)

2024

  1. Evaluation of the clinical use of MGMT methylation in extracellular vesicle-based liquid biopsy as a tool for glioblastoma patient management

    Scientific Reports, Vol. 14, Núm. 1

  2. Role of cfDNA and ctDNA to improve the risk stratification and the disease follow-up in patients with endometrial cancer: towards the clinical application

    Journal of Experimental and Clinical Cancer Research, Vol. 43, Núm. 1

2023

  1. Effectiveness of a novel gene nanotherapy based on putrescine for cancer treatment

    Biomaterials Science, Vol. 11, Núm. 12, pp. 4210-4225

  2. Erratum: Correction: Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer (Cancer research (2017) 77 21 (5846-5859))

    Cancer research

  3. Erratum: Effectiveness of a novel gene nanotherapy based on putrescine for cancer treatment (Biomaterials Science (2023) DOI: 10.1039/d2bm01456d

    Biomaterials Science

  4. Noninvasive detection of microsatellite instability in patients with endometrial cancer

    International Journal of Cancer, Vol. 152, Núm. 10, pp. 2206-2217

2022

  1. Improving the Management of Endometrial Cancer Patients through the Use of Liquid Biopsy Analyses: A Case Report

    International Journal of Molecular Sciences, Vol. 23, Núm. 15

  2. Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression

    Oncogene, Vol. 41, Núm. 13, pp. 1835-1850

  3. Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma

    Gut, Vol. 72, Núm. 2, pp. 345-359

2020

  1. Circulating Tumor Cells Characterization Revealed TIMP1 as a Potential Therapeutic Target in Ovarian Cancer

    Cells, Vol. 9, Núm. 5

  2. Genomic profiling of uterine aspirates and cfDNA as an integrative liquid biopsy strategy in endometrial cancer

    Journal of Clinical Medicine, Vol. 9, Núm. 2

  3. Looking for a better characterization of triple-negative breast cancer by means of circulating tumor cells

    Journal of Clinical Medicine, Vol. 9, Núm. 2

2019

  1. Exosome-mimetic nanoplatforms for targeted cancer drug delivery

    Journal of nanobiotechnology, Vol. 17, Núm. 1, pp. 85

  2. Extracellular vesicles-based biomarkers represent a promising liquid biopsy in endometrial cancer

    Cancers, Vol. 11, Núm. 12

2018

  1. ARole forCXCR4in peritonealandhematogenous ovarian cancer dissemination

    Molecular Cancer Therapeutics, Vol. 17, Núm. 2, pp. 532-543

2017

  1. Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma

    International Journal of Cancer, Vol. 140, Núm. 7, pp. 1551-1563

  2. Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers

    Modern Pathology, Vol. 30, Núm. 1, pp. 134-145

  3. Lysyl oxidase-like protein LOXL2 promotes lung metastasis of breast cancer

    Cancer Research, Vol. 77, Núm. 21, pp. 5846-5859

2015

  1. Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer

    International Journal of Cancer, Vol. 136, Núm. 8, pp. 1863-1873

2014

  1. Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer

    Molecular Cancer, Vol. 13, Núm. 1